TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Predictive Oncology ( (POAI) ) has provided an update.
On October 8, 2025, Predictive Oncology announced the closing of two private placements totaling approximately $343.5 million, which occurred on October 7, 2025. The funds will support the company’s new digital asset treasury strategy focused on ATH, a utility token of the Aethir ecosystem. This initiative aligns with Predictive Oncology’s AI-driven drug discovery efforts and aims to enhance Aethir’s infrastructure for AI and machine learning globally. The strategic move is expected to create significant value for the company and its shareholders.
The most recent analyst rating on (POAI) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.
Spark’s Take on POAI Stock
According to Spark, TipRanks’ AI Analyst, POAI is a Neutral.
The overall stock score is primarily impacted by the company’s poor financial performance, characterized by declining revenues and negative profit margins. Technical analysis provides some support with mixed signals, but the valuation remains unattractive due to negative earnings and no dividend yield. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on POAI stock, click here.
More about Predictive Oncology
Predictive Oncology is a leader in utilizing artificial intelligence and machine learning to accelerate drug discovery and development, particularly for cancer treatment. The company offers a scientifically validated AI platform, PEDAL, which predicts tumor response to drug compounds with high accuracy, supported by a vast biobank of human tumor samples and a CLIA laboratory facility. Headquartered in Pittsburgh, PA, Predictive Oncology collaborates with academic and industry partners to provide comprehensive AI-based drug discovery solutions.
Average Trading Volume: 80,309
Technical Sentiment Signal: Sell
Current Market Cap: $10.9M
See more data about POAI stock on TipRanks’ Stock Analysis page.